Advertisement

Topics

Turnstone Biologics Appoints Dr. Mike Burgess as President of Research and Development

08:00 EST 15 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Turnstone Biologics, a clinical-stage immuno-oncology company, today announced the appointment of Mike Burgess, MBChB, Ph.D., as president of research and development. Dr. Burgess joins from Bristol-Myers Squibb, where he was se...

Other Sources for this Article

for Turnstone Biologics
Paula Gitis, 415-946-1083
pgitis@purecommunications.com

NEXT ARTICLE

More From BioPortfolio on "Turnstone Biologics Appoints Dr. Mike Burgess as President of Research and Development"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...